- Home
- ZLAB vs SHO Comparison
ZLAB vs SHO Comparison
Compare ZLAB & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- SHO
- Stock Information
- Founded
- ZLAB 2013
- SHO 1995
- Country
- ZLAB China
- SHO United States
- Employees
- ZLAB N/A
- SHO N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- SHO Hotels/Resorts
- Sector
- ZLAB Health Care
- SHO Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- SHO Nasdaq
- Market Cap
- ZLAB 3.6B
- SHO 1.7B
- IPO Year
- ZLAB 2017
- SHO 1995
- Fundamental
- Price
- ZLAB $32.54
- SHO $9.16
- Analyst Decision
- ZLAB Buy
- SHO Hold
- Analyst Count
- ZLAB 5
- SHO 8
- Target Price
- ZLAB $54.28
- SHO $9.56
- AVG Volume (30 Days)
- ZLAB 782.4K
- SHO 2.7M
- Earning Date
- ZLAB 08-05-2025
- SHO 08-06-2025
- Dividend Yield
- ZLAB N/A
- SHO 3.89%
- EPS Growth
- ZLAB N/A
- SHO N/A
- EPS
- ZLAB N/A
- SHO 0.10
- Revenue
- ZLAB $418,326,000.00
- SHO $922,708,000.00
- Revenue This Year
- ZLAB $44.07
- SHO $7.67
- Revenue Next Year
- ZLAB $49.13
- SHO $3.45
- P/E Ratio
- ZLAB N/A
- SHO $92.87
- Revenue Growth
- ZLAB 43.72
- SHO N/A
- 52 Week Low
- ZLAB $16.01
- SHO $7.45
- 52 Week High
- ZLAB $44.34
- SHO $12.41
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- SHO 59.10
- Support Level
- ZLAB $34.26
- SHO $8.70
- Resistance Level
- ZLAB $35.72
- SHO $9.30
- Average True Range (ATR)
- ZLAB 1.12
- SHO 0.24
- MACD
- ZLAB -0.54
- SHO 0.04
- Stochastic Oscillator
- ZLAB 3.83
- SHO 83.57
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.